Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Change in Working Capital

-$366.00K

Quarterly · Period ending: · USD

LCTX logo

LCTX Change in Working Capital

Latest reported-$366.00K
LCTX Quarterly Change in Working Capital ($4.30M → -$366.00K)
High-resolution chart · PNG

LCTX change in working capital history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Change in Working Capital — Quarterly (USD)
Period endingChange in Working Capital (USD)
218,892
-199,957
160,759
-120,596
165,470
-456,760
40,369
1,300,000
-700,000
-200,000
-100,000
-200,000
-500,000
-100,000
2,800,000
-400,000
-700,000
-500,000
-900,000
-200,000
-500,000
3,700,000
-900,000
3,500,000
-300,000
-200,000
-300,000
-300,000
-400,000
1,200,000
-200,000
-300,000
4,300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.